Navigation Links
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Date:11/27/2007

CONSHOHOCKEN, PA and VANCOUVER, BC, Nov. 27 /PRNewswire/ - Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs, announced today that Jeffrey Arcara and Gene Wright have joined Neuromed as Vice President of Business Development and Vice President of Project Leadership, respectively. Both are newly created positions.

Mr. Arcara will be responsible for evaluating and negotiating in-licensing opportunities to complement our three pain programs including NMED-1077 (OROS(R) Hydromorphone) and our N- and T-type calcium channel blockers.

Dr. Wright will oversee project planning and will be involved in corporate strategic planning, development management processes and project management from conception through development cycle.

"Jeff's and Gene's direct experience with pain therapies, including opioids, will be immediately valuable to Neuromed as we advance our pivotal Phase 3 trials of NMED-1077 for the treatment of chronic pain," said Dr. Christopher Gallen, President & CEO. "Our ability to attract the caliber of seasoned executives such as Jeff and Gene is a testament to the enthusiasm around our programs and our potential to develop and market new and improved pain medicines. It is a pleasure to welcome them to our team."

About Jeffrey Arcara

Mr. Arcara was most recently an Executive Director of Marketing at Wyeth, where he was leading a commercial launch team for the investigational drug subcutaneous methylnaltrexone, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in patients receiving palliative care. Prior to Wyeth, Mr. Arcara was Vice President of Commercial Operations at InKine Pharmaceuticals. He has also held positions with Centocor and Abbott. Mr. Arcara received his M.B.A. in Marketing-Finance from the Anderson Graduate School of Management at UCLA and a B.A. in Marketing-Finance from the University of Wisconsin.

<
'/>"/>
SOURCE Neuromed Pharmaceuticals Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
2. WorldHeart Appoints David Pellone Chief Financial Officer
3. Novo Nordisk Appoints New Leader of North American Business
4. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
5. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
6. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
7. Resonant Medical Appoints New Vice President of Global Sales
8. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
9. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
10. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
11. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009).... 27 Allrecipes.com , the world... traffic numbers, with more than 2.8 million visit... picture of what was served on the biggest food ho...n 2009 weighed in at 2,225 calories per serving, a...ing to the Allrecipes site, Sweet Potato Pie I s...
(Date:11/27/2009)...bilingual coloring books designed for children age...ity to educate - inform parents and children alike...nosuars to ABC,S and a host of other topics. , ...mber 27, 2009 -- Today’s children have enoug...ny hour of the day, but one of the oldest and simp...
(Date:11/27/2009)...ractive anatomy education apps from Modality and L...ences learning opportunities for iPhone and iPod t... November 27, 2009 -- Modality, Inc. and Lippinc...lters Kluwer Health, today announced the availabil... Store. Clemente’s Anatomy, Rohen’s Ph...
(Date:11/26/2009)...PRNewswire/ -- The diabetes population in the Unit...s and annual medical spending on the disease is pr...today, according to a study published in the Decem...ing Diabetes ® Program (NCDP), a program of N...rom the University of Chicago. ,, According to ...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...asdaq: ENDO ), an innovative medical device compa...e technologies for tissue and tumor,ablation, toda...or,presentation at the Oppenheimer 19th Annual Hea...ty., A live webcast of the Company,s presentation...
...e-FirstCall/ -- Mindray,Medical International Limi...r,and marketer of medical devices worldwide today ...s for the third quarter ended September 30,2008, a...stern Time (9:00 p.m. on November 11, 2008 Beijing...
...ch Outsourcing (CRO), which came into being in the... pharmaceutical market scenario. Demand for CRO se...ure on pharma and biotech companies to lower costs... San Jose, California (PRWEB), October 22, 20...
...s preparing for its next clinical trial of Cytolin... body,s own immune system to fight the virus. The ...making big changes that include relocating to a la...lly more treatable now than during the height of t...
...ited (ASX:,BKL) today announced a net profit after... 30 September 2008, representing a 17.8% increase ...were up 3.4% to AUS$46.8,million., This first qua...nvironment, including the volatility in the,Austra...
...learn the signs of poor heart health, how to diagn...lives , St. Joseph, Mo. (...ciple cause of death in dogs, affecting more than ...pet owners about how to protect and care for their...
Other Medicine News:Health News:Endocare to Present at Oppenheimer 19th Annual Healthcare Conference 2Health News:Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008 2Health News:Contract Research Outsourcing Market to Exceed $26.2 Billion by 2012, According to a New Report by Global Industry Analysts, Inc. 2Health News:Contract Research Outsourcing Market to Exceed $26.2 Billion by 2012, According to a New Report by Global Industry Analysts, Inc. 3Health News:Contract Research Outsourcing Market to Exceed $26.2 Billion by 2012, According to a New Report by Global Industry Analysts, Inc. 4Health News:CytoDyn, Inc. Prepares for New Clinical of Its First-In-Class Drug for Treating HIV/AIDS 2Health News:CytoDyn, Inc. Prepares for New Clinical of Its First-In-Class Drug for Treating HIV/AIDS 3Health News:Blackmores' First Quarter Announcement 2Health News:New Web Site Devoted to Canine Heart Disease - A Leading Cause of Death in Dogs 2
(Date:11/25/2009)... AMPAC Fine Chemicals LLC (AFC), a ...: APFC ) announced today that it received the Env... at the Annual Statewide Environmental Summit, spo...ogy Association (CMTA), the Industrial Environment...ncil of California (CICC) held in San Diego. This...
(Date:11/25/2009)...ire/ -- Reportlinker.com announces that a new mark...,, United States Dental Devices Market Analysi...inker.com/p0158733/United-States-Dental-Devices-Ma...ited States Dental Devices Market Analysis and For...s an essential source for in-depth information and...
(Date:11/25/2009)... Swissray International, Inc. a le... ddR ) systems, announced today that its operation...ith a long term view towards growing Swissray,s me...assets and intellectual property, as well as contr...growth Swissray is now poised to move to the next ...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 62104 1Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 62104 2Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 62104 3Intriguing Scientific Results from World 26apos 3Bs Largest Intention Healing Project 3A DreamHealer 62101 1Intriguing Scientific Results from World 26apos 3Bs Largest Intention Healing Project 3A DreamHealer 62101 2New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 1New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 2New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 3
...dded to hormone therapy, following surgery, signif...eath by 36% beyond clinical benefits ac... may allow clinicians to improve standard of care ...ensitive, early-stage breast ...om a large clinical program exploring the, direc...
... updated results from Phase III clinical trial --,... Takeda,Oncology Company, today announced the pres...lti-center, randomized Phase III clinical trial, c...stine, adriamycin and,dexamethasone (VAD). Results...ercent in the VcD arm as induction therapy and 35 ...
Other Medicine Technology:Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: